✨ Government Inquiry and Trade Name Registration
NEW ZEALAND GAZETTE, No. 148 — 11 DECEMBER 2014
iii. border controls to prevent prisoners from departing New Zealand.
d. any other matters relevant to the above matters, to the extent necessary to provide a complete report of these matters.
The inquiry may be informed by any departmental or State services reviews that have been undertaken, including whether by specific public service departments or on a multi-agency basis.
Exclusions from Inquiry and Scope of Recommendations
In accordance with section 11 of the Inquiries Act 2013 ("Act"), this Inquiry will not determine the civil, criminal or disciplinary liability of any person. This Inquiry may, as provided in section 16 of the Act, be postponed or temporarily suspended.
Reporting Sequence
The Inquiry is to report its findings and opinions to the appointing Minister in writing by 30 June 2015.
Consideration of Evidence
The Inquiry may begin considering evidence on 15 December 2014, after the Terms of Reference have been published in the New Zealand Gazette.
Relevant Department
For the purposes of section 4 of the Act, the State Services Commission is the relevant department for the Inquiry and responsible for administrative matters relating to the Inquiry.
Dated at Wellington this 9th day of December 2014.
Hon PAULA BENNETT, Minister of State Services.
2014-go7634
Notice of Application to Register a Trade Name Product (Notice No. MPI 430)
Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 ("the Act"), that the following application has been made to register a trade name product under section 9(1) of the Act:
Trade Name: Pexion 400 mg Tablets for Dogs
Reference: A010987
Active Ingredient and Concentration:
Imepitoin 400mg
Formulation Type: Tablet
General Use Claim:
Imepitoin is an antiepileptic agent for use as an aid in the treatment of idiopathic epilepsy in dogs.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
a. must state in full the reasons for making the submission; and
b. may state any decision sought on that application; and
c. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
a. where submissions on this application are to be sent; and
b. where requests for copies of the public information relating to the application can be sent; and
c. where public information relating to the application can be viewed; and
d. the director-general’s address for service:
59
Next Page →
NZ Gazette 2014, No 148
✨ LLM interpretation of page content
⚖️
Establishment of Government Inquiry into Escape of Phillip John Smith / Traynor
(continued from previous page)
⚖️ Justice & Law Enforcement9 December 2014
Inquiry, Escape, Prisoner, Phillip John Smith, Phillip John Traynor, Government Inquiry, Inquiries Act 2013, Border Controls, State Services Commission
- Hon Paula Bennett, Minister of State Services
🌾 Application to Register a Trade Name Product
🌾 Primary Industries & ResourcesTrade Name Registration, Agricultural Compounds, Veterinary Medicines, Pexion 400 mg Tablets for Dogs, Imepitoin, Antiepileptic Agent
- Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries